Molecular editing of kinase-targeting Resorcylic Acid Lactones (RAL): Fluoroenone RAL

ChemMedChem

Volumn 5, Issue 5, 2010, Pages 670-673

  Jogireddy, Rajamalleswaramma ^a   Barluenga, Sofia ^a   Winssinger, Nicolas ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Fluorine; Irreversible inhibitors; Kinases; Resorcylic acid lactones; VEGF

Indexed keywords

FLUOROENONE 1; FLUOROENONE 2; LACTONE DERIVATIVE; LL Z1640 2; NATURAL PRODUCT; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; DRUG TARGETING; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INHIBITION KINETICS; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING;

BINDING SITES; FLUORINE; LACTONES; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-KIT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77951686876     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201000047     Document Type: Article

References (21)

1. J. Zhang, P. L. Yang, N. S. Gray, Nat. Rev. Cancer 2009, 9, 28-39.
2. A. Schirmer, J. Kennedy, S. Murli, R. Reid, D. V. Santi, Proc. Natl. Acad. Sci. USA 2006, 103, 4234-4239.
3. H. Tanaka, K. Nishida, K. Sugita, T. Yoshioka, Jpn. J. Cancer Res. 1999, 90, 1139-1145.
4. G. A. Ellestad, F. M. Lovell, N. A. Perkinson, R. T. Hargreaves, W. J. McGahren, J. Org. Chem. 1978, 43, 2339-2343.
5. J. Ninomiya-Tsuji, T. Kajino, K. Ono, T. Ohtomo, M. Matsumoto, M. Shiina, M. Mihara, M. Tsuchiya, K. Matsumoto, J. Biol. Chem. 2003, 278, 18485-18490.
6. A. Zhao, S. H. Lee, M. Mojena, R. G. Jenkins, D. R. Patrick, H. E. Huber, M. A. Goetz, O. D. Hensens, D. L. Zink, D. Vilella, A. W. Dombrowski, R. B. Lingham, L. Huang, J. Antibiot. 1999, 52, 1086-1094.
7. P. Y. Dakas, S. Barluenga, F. Totzke, U. Zirrgiebel, N. Winssinger, Angew. Chem. 2007, 119, 7023-7026;
8. Angew. Chem. Int. Ed. 2007, 46, 6899-6902.
9. T. Kastelic, J. Schnyder, A. Leutwiler, R. Traber, B. Streit, H. Niggli, A. Mackenzie, D. Cheneval, Cytokine 1996, 8, 751-761.
10. a) N. Winssinger, S. Barluenga, Chem. Commun. 2007, 22-36;
11. b) S. Barluenga, P. Dakas, M. Boulifa, E. Moulin, N. Winssinger, C. R. Chim. 2008, 11, 1306-1317;
12. c) T. Hofmann, K.-H. Altmann, C. R. Chim. 2008, 11, 1318-1335.
13. P. Y. Dakas, R. Jogireddy, G. Valot, S. Barluenga, N. Winssinger, Chem. Eur. J. 2009, 15, 11490-11497.
14. R. Jogireddy, P. Y. Dakas, G. Valot, S. Barluenga, N. Winssinger, Chem. Eur. J. 2009, 15, 11498-11506.
15. H. Du, T. Matsushima, M. Spyvee, M. Goto, H. Shirota, F. Gusovsky, K. Chiba, M. Kotake, N. Yoneda, Y. Eguchi, L. DiPietro, J.-C. Harmange, S. Gilbert, X.-Y. Li, H. Davis, Y. Jiang, Z. Zhang, R. Pelletier, N. Wong, H. Sakurai, H. Yang, H. Ito-Igarashi, A. Kimura, Y. Kuboi, Y. Mizui, I. Tanaka, M. Ikemori-Kawada, Y. Kawakami, A. Inoue, T. Kawai, Y. Kishi, Y. Wang, Bioorg. Med. Chem. Lett. 2009, 19, 6196-6199.
16. R. M. Wilson, S. J. Danishefsky, J. Org. Chem. 2006, 71, 8329-8351.
17. S. Barluenga, P.-Y. Dakas, Y. Ferandin, L. Meijer, N. Winssinger, Angew. Chem. 2006, 118, 4055-4058;
18. Angew. Chem. Int. Ed. 2006, 45, 3951-3954.
19. T. Hofmann, K.-H. Altmann, Synlett 2008, 1500-1504.
20. P. Selles, R. Lett, Tetrahedron Lett. 2002, 43, 4627-4631.
21. M. Goto, J. Chow, K. Muramoto, K. Chiba, S. Yamamoto, M. Fujita, H. Obaishi, K. Tai, Y. Mizui, I. Tanaka, D. Young, H. Yang, Y. J. Wang, H. Shirota, F. Gusovsky, J. Pharmacol. Exp. Ther. 2009, 331, 485-495.